{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:01:16Z","timestamp":1793815276491,"version":"4.6.1"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS110721"],"award-info":[{"award-number":["NS110721"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bioactmat.2024.09.016","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T22:23:32Z","timestamp":1727130212000},"page":"145-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Nanotechnology approaches to drug delivery for the treatment of ischemic stroke"],"prefix":"10.1016","volume":"43","author":[{"given":"Bin","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-7751","authenticated-orcid":false,"given":"Farrah S.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-4506","authenticated-orcid":false,"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-5360","authenticated-orcid":false,"given":"Jiangbing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2024.09.016_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","article-title":"Global and regional burden of stroke during 1990-2010: findings from the global burden of disease study 2010","volume":"383","author":"Feigin","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib2","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the american heart association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCOUTCOMES.111.000095","article-title":"Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines-stroke hospitals","volume":"6","author":"Schwamm","year":"2013","journal-title":"Circ. Cardiovas. Qual. Outcome"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1917030","article-title":"Acute ischemic stroke","volume":"383","author":"Powers","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jama.2020.26867","article-title":"Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review","volume":"325","author":"Mendelson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(19)31053-0","article-title":"Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data","volume":"394","author":"Campbell","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nn.3059","article-title":"The voltage-gated proton channel hv1 enhances brain damage from ischemic stroke","volume":"15","author":"Wu","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature13909","article-title":"Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ros","volume":"515","author":"Chouchani","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nm.2387","article-title":"Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly (adp-ribose) polymer-induced cell death","volume":"17","author":"Andrabi","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3804979","article-title":"Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy","volume":"2018","author":"Sun","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib12","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/ncomms4413","article-title":"Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity","volume":"5","author":"Yao","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12031-011-9496-4","article-title":"Specific role of tight junction proteins claudin-5, occludin, and zo-1 of the blood-brain barrier in a focal cerebral ischemic insult","volume":"44","author":"Jiao","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/jcbfm.2013.169","article-title":"Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo\/in vitro study","volume":"34","author":"Kuntz","year":"2014","journal-title":"J. Cerebr. Blood Flow Metabol. : Offic. J. Int. Soc. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10523","article-title":"Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury","volume":"7","author":"Shi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2020.03.037","article-title":"Targeting aquaporin-4 subcellular localization to treat central nervous system edema","volume":"181","author":"Kitchen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib17","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41401-020-00503-5","article-title":"Drug development in targeting ion channels for brain edema","volume":"41","author":"Luo","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0271678X18806893","article-title":"Involvement of caveolin-1 in neurovascular unit remodeling after stroke: effects on neovascularization and astrogliosis","volume":"40","author":"Blochet","year":"2020","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib19","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1093\/nar\/gkz766","article-title":"Hif-transcribed p53 chaperones hif-1\u03b1","volume":"47","author":"Madan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11499","article-title":"Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke","volume":"7","author":"Szalay","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/jcbfm.2015.45","article-title":"Targeting neutrophils in ischemic stroke: translational insights from experimental studies","volume":"35","author":"Jickling","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib23","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1038\/s41467-020-16191-y","article-title":"Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke","volume":"11","author":"Kang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12576-016-0516-6","article-title":"Time-course investigation of blood-brain barrier permeability and tight junction protein changes in a rat model of permanent focal ischemia","volume":"68","author":"Liu","year":"2018","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1017\/S0317167100000421","article-title":"Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia","volume":"26","author":"Huang","year":"1999","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171558","article-title":"Evolution of blood-brain-barrier permeability after acute ischemic stroke","volume":"12","author":"Merali","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.20199","article-title":"Early blood-brain barrier disruption in human focal brain ischemia","volume":"56","author":"Latour","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib28","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1161\/01.STR.0000144051.32131.09","article-title":"Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption","volume":"35","author":"Warach","year":"2004","journal-title":"Stroke; J. Cereb. Circ."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.586226","article-title":"Characterization of the blood brain barrier disruption in the photothrombotic stroke model","volume":"11","author":"Weber","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/STROKEAHA.108.522847","article-title":"Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke","volume":"40","author":"Bang","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nn.2953","article-title":"Stroke research at a crossroad: asking the brain for directions","volume":"14","author":"Iadecola","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(13)70223-0","article-title":"High-dose albumin treatment for acute ischaemic stroke (alias) part 2: a randomised, double-blind, phase 3, placebo-controlled trial","volume":"12","author":"Ginsberg","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib33","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/STROKEAHA.113.001531","article-title":"Granulocyte colony\u2013stimulating factor in patients with acute ischemic stroke: results of the ax200 for ischemic stroke trial","volume":"44","author":"Ringelstein","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib34","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1161\/STROKEAHA.113.000780","article-title":"Intravenous minocycline in acute stroke: a randomized, controlled pilot study and meta-analysis","volume":"44","author":"Kohler","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1747-4949.2012.00901.x","article-title":"A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-pa) and cerebrolysin in acute ischaemic hemispheric stroke","volume":"8","author":"Lang","year":"2013","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1474-4422(14)70054-7","article-title":"Safety and efficacy of uric acid in patients with acute stroke (urico-ictus): a randomised, double-blind phase 2b\/3 trial","volume":"13","author":"Chamorro","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.016371","article-title":"Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: a pilot trial","volume":"132","author":"Zhu","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-015-0761-8","article-title":"Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial","volume":"19","author":"Tsai","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib39","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1474-4422(16)30196-X","article-title":"Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (games-rp): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"15","author":"Sheth","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib40","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.116.015664","article-title":"Paramedic initiation of neuroprotective agent infusions: successful achievement of target blood levels and attained level effect on clinical outcomes in the fast-mag pivotal trial (field administration of stroke therapy\u2013magnesium)","volume":"48","author":"Shkirkova","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","article-title":"Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (masters): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"16","author":"Hess","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib42","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11055-018-0652-y","article-title":"Results of a randomized, double-blind, multicenter, placebo-controlled, parallel-group study of the efficacy and safety of mexidol in prolonged sequential therapy of patients in the acute and early recovery stages of hemispheric stroke (the epica study)","volume":"48","author":"Stakhovskaya","year":"2018","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib43","first-page":"e1091","article-title":"Natalizumab in acute ischemic stroke (action ii): a randomized, placebo-controlled trial","volume":"95","author":"Elkind","year":"2020","journal-title":"Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1474-4422(20)30004-1","article-title":"Safety and efficacy of gabaa \u03b15 antagonist s44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"19","author":"Chabriat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib45","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (escape-na1): a multicentre, double-blind, randomised controlled trial","volume":"395","author":"Hill","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib46","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/STROKEAHA.120.031197","article-title":"Edaravone dexborneol versus edaravone alone for the treatment of acute ischemic stroke: a phase iii, randomized, double-blind, comparative trial","volume":"52","author":"Xu","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib47","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1161\/STROKEAHA.113.002881","article-title":"Distribution of national institutes of health stroke scale in the cincinnati\/northern Kentucky stroke study","volume":"44","author":"Reeves","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib48","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1161\/STROKEAHA.114.006884","article-title":"Brain edema predicts outcome after nonlacunar ischemic stroke","volume":"45","author":"Battey","year":"2014","journal-title":"Stroke; J. Cereb. Circ."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib49","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0271678X15617172","article-title":"Molecular pathophysiology of cerebral edema","volume":"36","author":"Stokum","year":"2016","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.716825","article-title":"Cerebral edema formation after stroke: emphasis on blood-brain barrier and the lymphatic drainage system of the brain","volume":"15","author":"Chen","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib51","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1474-4422(07)70055-8","article-title":"Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications","volume":"6","author":"Simard","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jcbfm.2011.159","article-title":"Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of abcc8","volume":"32","author":"Woo","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol. : Offic. J. Int. Soc. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm1390","article-title":"Newly expressed sur1-regulated nc(ca-atp) channel mediates cerebral edema after ischemic stroke","volume":"12","author":"Simard","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ana.23680","article-title":"Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas","volume":"72","author":"Kunte","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib55","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/NEN.0b013e3182a32e40","article-title":"Sulfonylurea receptor 1 expression in human cerebral infarcts","volume":"72","author":"Mehta","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib56","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1523\/JNEUROSCI.21-17-06512.2001","article-title":"Cell swelling and a nonselective cation channel regulated by internal ca2+ and atp in native reactive astrocytes from adult rat brain","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci. Offic. J. Soc. Neurosci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib57","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/jcbfm.2012.91","article-title":"Sulfonylurea receptor 1 in central nervous system injury: a focused review","volume":"32","author":"Simard","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol. Offic. J. Int. Soc. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12028-014-9970-2","article-title":"Exploratory analysis of glyburide as a novel therapy for preventing brain swelling","volume":"21","author":"Sheth","year":"2014","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib59","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/STROKEAHA.108.522409","article-title":"Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke","volume":"40","author":"Simard","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib60","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.expneurol.2012.02.010","article-title":"Atp-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats","volume":"235","author":"Ortega","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/STROKEAHA.109.572644","article-title":"Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke","volume":"41","author":"Simard","year":"2010","journal-title":"Stroke; J. Cereb. Circ."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib62","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12975-012-0149-x","article-title":"Glibenclamide-10-h treatment window in a clinically relevant model of stroke","volume":"3","author":"Simard","year":"2012","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1749-6632.2012.06705.x","article-title":"Does inhibiting sur1 complement rt-pa in cerebral ischemia?","volume":"1268","author":"Simard","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib64","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/STROKEAHA.113.003352","article-title":"Pilot study of intravenous glyburide in patients with a large ischemic stroke","volume":"45","author":"Sheth","year":"2014","journal-title":"Stroke; J. Cereb. Circ."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12028-013-9917-z","article-title":"Glyburide is associated with attenuated vasogenic edema in stroke patients","volume":"20","author":"Kimberly","year":"2014","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib66","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1161\/STROKEAHA.119.026036","article-title":"Intravenous glibenclamide reduces lesional water uptake in large hemispheric infarction","volume":"50","author":"Vorasayan","year":"2019","journal-title":"Stroke; J. Cereb. Circ."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-pharmtox-010919-023429","article-title":"Emerging pharmacological treatments for cerebral edema: evidence from clinical studies","volume":"60","author":"Stokum","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib68","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1126\/science.1072873","article-title":"Treatment of ischemic brain damage by perturbing nmda receptor- psd-95 protein interactions","volume":"298","author":"Aarts","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib69","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm.2245","article-title":"Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nnos with psd-95","volume":"16","author":"Zhou","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib70","doi-asserted-by":"crossref","first-page":"154ra133","DOI":"10.1126\/scitranslmed.3003824","article-title":"A translational paradigm for the preclinical evaluation of the stroke neuroprotectant tat-nr2b9c in gyrencephalic nonhuman primates","volume":"4","author":"Cook","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib71","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1474-4422(12)70225-9","article-title":"Safety and efficacy of na-1 in patients with iatrogenic stroke after endovascular aneurysm repair (enact): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"11","author":"Hill","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb1498","article-title":"Plasmin-resistant psd-95 inhibitors resolve effect-modifying drug-drug interactions between alteplase and nerinetide in acute stroke","volume":"13","author":"Mayor-Nunez","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib73","unstructured":"https:\/\/spannetwork.Org\/uric_acid, access on August\/22\/2023."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1586\/14737175.8.2.259","article-title":"Uric acid administration in patients with acute stroke: a novel approach to neuroprotection","volume":"8","author":"Amaro","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib75","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/01.STR.22.12.1548","article-title":"Neurochemical analysis of focal ischemia in rats","volume":"22","author":"Uemura","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib76","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12975-016-0515-1","article-title":"Uric acid is protective after cerebral ischemia\/reperfusion in hyperglycemic mice","volume":"8","author":"Justicia","year":"2017","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib77","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.043","article-title":"Treatment with uric acid reduces infarct and improves neurologic function in female mice after transient cerebral ischemia","volume":"27","author":"Dhanesha","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.jcbfm.9600312","article-title":"Uric acid reduces brain damage and improves the benefits of rt-pa in a rat model of thromboembolic stroke","volume":"27","author":"Romanos","year":"2007","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib79","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s12975-018-0661-8","article-title":"Uric acid treatment after stroke prevents long-term middle cerebral artery remodelling and attenuates brain damage in spontaneously hypertensive rats","volume":"11","author":"Jim\u00e9nez-Xarri\u00e9","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/bc.bc_1_19","article-title":"Uric acid therapy for vasculoprotection in acute ischemic stroke","volume":"5","author":"Amaro","year":"2019","journal-title":"Brain Circ"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib81","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/hs0402.105927","article-title":"Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke","volume":"33","author":"Chamorro","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib82","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000346603","article-title":"Serum uric acid and outcome after acute ischemic stroke: premier study","volume":"35","author":"Chiquete","year":"2013","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib83","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1161\/STROKEAHA.106.480699","article-title":"A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke","volume":"38","author":"Amaro","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib84","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1747493016684354","article-title":"Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy","volume":"12","author":"Chamorro","year":"2017","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib85","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib86","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib87","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1161\/STROKEAHA.111.618215","article-title":"Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke","volume":"42","author":"Switzer","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib88","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/STROKEAHA.110.582601","article-title":"Minocycline to improve neurologic outcome in stroke (minos): a dose-finding study","volume":"41","author":"Fagan","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib89","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","article-title":"Minocycline treatment in acute stroke: an open-label, evaluator-blinded study","volume":"69","author":"Lampl","year":"2007","journal-title":"Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0028-3886.93584","article-title":"Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial","volume":"60","author":"Padma","year":"2012","journal-title":"Neurol. India"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-2-33","article-title":"Systematic review and stratified meta-analysis of the efficacy of rhoa and rho kinase inhibitors in animal models of ischaemic stroke","volume":"2","author":"Vesterinen","year":"2013","journal-title":"Syst. Rev."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib92","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuroscience.2012.06.015","article-title":"A rho kinase (rock) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator","volume":"220","author":"Ishiguro","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10571-008-9308-8","article-title":"Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats","volume":"29","author":"Li","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib94","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2017.11.107","article-title":"Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis","volume":"495","author":"Fukuta","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib95","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0024-3205(01)01229-2","article-title":"Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage","volume":"69","author":"Satoh","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib96","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2005.06.003","article-title":"Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial","volume":"238","author":"Shibuya","year":"2005","journal-title":"Journal of the neurological sciences"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib97","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3389\/fimmu.2019.02167","article-title":"The involvement and therapy target of immune cells after ischemic stroke","volume":"10","author":"Jian","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib98","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/00004647-199711000-00001","article-title":"Neuroprotective effects of inhibiting poly (adp-ribose) synthetase on focal cerebral ischemia in rats","volume":"17","author":"Takahashi","year":"1997","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib99","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/01.STR.0000250742.61241.79","article-title":"Use of a poly (adp-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion","volume":"38","author":"Hamby","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib100","doi-asserted-by":"crossref","DOI":"10.1161\/str.48.suppl_1.tp270","article-title":"Abstract tp270: interleukin-6 receptor inhibition with tocilizumab ameliorates ischemic stroke damage in mice","volume":"48","author":"Hudobenko","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib101","doi-asserted-by":"crossref","DOI":"10.1161\/str.50.suppl_1.128","article-title":"Amelioration of ischemic stroke damage through inhibition of interleukin-6 signaling with tocilizumab requires sex specific dosing","volume":"50","author":"Hudobenko","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib102","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.2174\/0929867326666190308133732","article-title":"Fty720 (fingolimod) ameliorates brain injury through multiple mechanisms and is a strong candidate for stroke treatment","volume":"27","author":"Wang","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib103","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00207454.2012.749255","article-title":"Systematic review and meta-analysis of the efficacy of sphingosine-1-phosphate (s1p) receptor agonist fty720 (fingolimod) in animal models of stroke","volume":"123","author":"Liu","year":"2013","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib104","doi-asserted-by":"crossref","first-page":"18315","DOI":"10.1073\/pnas.1416166111","article-title":"Impact of an immune modulator fingolimod on acute ischemic stroke","volume":"111","author":"Fu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.25352","article-title":"Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow","volume":"84","author":"Tian","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib106","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.nano.2016.03.005","article-title":"Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles","volume":"12","author":"Han","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib107","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.STR.22.8.1032","article-title":"Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia","volume":"22","author":"Kaplan","year":"1991","journal-title":"Stroke; J. Cereb. Circ."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib108","first-page":"e1009","article-title":"Multivariable prediction model for futile recanalization therapies in patients with acute ischemic stroke","volume":"99","author":"Meinel","year":"2022","journal-title":"Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib109","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1208\/s12248-013-9514-2","article-title":"Effects of selected oatp and\/or abc transporter inhibitors on the brain and whole-body distribution of glyburide","volume":"15","author":"Tournier","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134476","article-title":"Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents","volume":"10","author":"Lahmann","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib111","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","article-title":"The blood-brain barrier and cancer: transporters, treatment, and trojan horses","volume":"13","author":"Deeken","year":"2007","journal-title":"Clin. Cancer Res. : Offic. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib112","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1166\/jnn.2014.9119","article-title":"Nanoparticles and blood-brain barrier: the key to central nervous system diseases","volume":"14","author":"Dominguez","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib113","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","article-title":"Polymeric nanoparticles for drug delivery to the central nervous system","volume":"64","author":"Patel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/PPO.0b013e318244d8ae","article-title":"Novel delivery strategies for glioblastoma","volume":"18","author":"Zhou","year":"2012","journal-title":"Cancer J."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib115","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1021\/nn300240p","article-title":"Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier","volume":"6","author":"Qiao","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib116","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1016\/j.biomaterials.2013.08.030","article-title":"Choline transporter-targeting and co-delivery system for glioma therapy","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib117","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/bip.20998","article-title":"Polymeric micelles anchored with tat for delivery of antibiotics across the blood-brain barrier","volume":"90","author":"Liu","year":"2008","journal-title":"Biopolymers"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib118","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1158\/0008-5472.CAN-09-1157","article-title":"Specific targeting of brain tumors with an optical\/magnetic resonance imaging nanoprobe across the blood-brain barrier","volume":"69","author":"Veiseh","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib119","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nmat3187","article-title":"Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery","volume":"11","author":"Zhou","year":"2011","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib120","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1073\/pnas.1304504110","article-title":"Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma","volume":"110","author":"Zhou","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib121","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.biomaterials.2011.09.061","article-title":"Octa-functional plga nanoparticles for targeted and efficient sirna delivery to tumors","volume":"33","author":"Zhou","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201808361","article-title":"Microthrombus\u2010targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke","volume":"31","author":"Lu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib123","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1021\/acsnano.8b04787","article-title":"Thrombin-responsive, brain-targeting nanoparticles for improved stroke therapy","volume":"12","author":"Guo","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib124","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s12274-020-2930-6","article-title":"The enhanced protective effects of salvianic acid a: a functionalized nanoparticles against ischemic stroke through increasing the permeability of the blood-brain barrier","volume":"13","author":"Li","year":"2020","journal-title":"Nano Res."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib125","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1039\/C1CS15242D","article-title":"Multifunctional dendritic polymers in nanomedicine: opportunities and challenges","volume":"41","author":"Khandare","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib126","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/jacs.6b11013","article-title":"Comprehensive insights into the multi-antioxidative mechanisms of melanin nanoparticles and their application to protect brain from injury in ischemic stroke","volume":"139","author":"Liu","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib127","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/STROKEAHA.106.467290","article-title":"Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery","volume":"38","author":"Kawaguchi","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib128","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/aor.12358","article-title":"Efficacy of liposome\u2010encapsulated hemoglobin in a rat model of cerebral ischemia","volume":"38","author":"Kaneda","year":"2014","journal-title":"Artif. Organs"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/jpet.109.160051","article-title":"Liposome-encapsulated hemoglobin ameliorates ischemic stroke in nonhuman primates: an acute study","volume":"332","author":"Kawaguchi","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2016.01.017","article-title":"Intranasal delivery of bfgf with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model","volume":"224","author":"Zhao","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib131","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s12274-019-2470-0","article-title":"Single small molecule-assembled nanoparticles mediate efficient oral drug delivery","volume":"12","author":"Yang","year":"2019","journal-title":"Nano Res."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib132","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1021\/acs.molpharmaceut.0c00044","article-title":"Synergistic chemotherapy for breast cancer and breast cancer brain metastases via paclitaxel-loaded oleanolic acid nanoparticles","volume":"17","author":"Bao","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib133","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.7150\/thno.35791","article-title":"Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles","volume":"9","author":"Deng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113868","article-title":"Phytonanomaterials as therapeutic agents and drug delivery carriers","volume":"176","author":"Xie","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib135","first-page":"57","article-title":"Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery","volume":"16","author":"Zhang","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib136","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1039\/C8CS00457A","article-title":"Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (ii)","volume":"48","author":"Wu","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib137","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1002\/anie.201203780","article-title":"Ceria nanoparticles that can protect against ischemic stroke","volume":"51","author":"Kim","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib138","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1021\/acsnano.8b01994","article-title":"Simultaneous blood\u2013brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles","volume":"12","author":"Bao","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib139","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9751","article-title":"Highly bioactive zeolitic imidazolate framework-8\u2013capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke","volume":"6","author":"He","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib140","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1039\/C7SC05476A","article-title":"Ros scavenging mn 3 o 4 nanozymes for in vivo anti-inflammation","volume":"9","author":"Yao","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib141","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1002\/ange.201600868","article-title":"Self\u2010assembly of multi\u2010nanozymes to mimic an intracellular antioxidant defense system","volume":"128","author":"Huang","year":"2016","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib142","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/acs.nanolett.9b04974","article-title":"Bioinspired nanosponge for salvaging ischemic stroke via free radical scavenging and self-adapted oxygen regulating","volume":"20","author":"Shi","year":"2019","journal-title":"Nano Lett."},{"issue":"11","key":"10.1016\/j.bioactmat.2024.09.016_bib143","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1021\/acs.nanolett.1c00719","article-title":"Oxygen-generating cyanobacteria powered by upconversion-nanoparticles-converted near-infrared light for ischemic stroke treatment","volume":"21","author":"Wang","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803888","article-title":"Activatable protein nanoparticles for targeted delivery of therapeutic peptides","volume":"30","author":"Yu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib145","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/nnano.2014.274","article-title":"Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury","volume":"9","author":"Gaudin","year":"2014","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib146","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax7964","article-title":"Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke","volume":"5","author":"Zhang","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib147","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41582-018-0126-4","article-title":"Exosomes\u2014beyond stem cells for restorative therapy in stroke and neurological injury","volume":"15","author":"Zhang","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib148","first-page":"1272","article-title":"Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke","volume":"13","author":"Dong","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib149","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202006169","article-title":"Engineering stem cell derived biomimetic vesicles for versatility and effective targeted delivery","volume":"30","author":"Wu","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib150","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nnano.2015.330","article-title":"Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers","volume":"11","author":"Schottler","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib151","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/jcbfm.2014.220","article-title":"Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection","volume":"35","author":"Yemisci","year":"2015","journal-title":"J Cerebr Blood F Met"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib152","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2217\/nnm.11.21","article-title":"A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke","volume":"6","author":"Marsh","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib153","article-title":"Brain targeting, antioxidant polymeric nanoparticles for stroke drug delivery and therapy","author":"Wu","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib154","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2016.04.038","article-title":"Dual targeted nanocarrier for brain ischemic stroke treatment","volume":"233","author":"Zhao","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib155","first-page":"1","article-title":"Enhanced anti-ischemic stroke of zl006 by t7-conjugated pegylated liposomes drug delivery system","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib156","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1021\/acsmacrolett.0c00054","article-title":"Synthesis of multiarm peptide dendrimers for dual targeted thrombolysis","volume":"9","author":"Zhang","year":"2020","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib157","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1039\/C8RA06688D","article-title":"Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke","volume":"9","author":"Dang","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib158","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7150\/thno.7088","article-title":"In vivo theranostics at the peri-infarct region in cerebral ischemia","volume":"4","author":"Agulla","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.02.033","article-title":"An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy","volume":"300","author":"Huang","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib160","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biomaterials.2013.09.093","article-title":"Targeted therapy of brain ischaemia using fas ligand antibody conjugated peg-lipid nanoparticles","volume":"35","author":"Lu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib161","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2016.75","article-title":"Bioresponsive materials","volume":"2","author":"Lu","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib164","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1126\/science.1217815","article-title":"Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels","volume":"337","author":"Korin","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/jamaneurol.2014.2886","article-title":"Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeutics","volume":"72","author":"Korin","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib166","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/scd.2017.0009","article-title":"Human neural stem cell therapy for chronic ischemic stroke: charting progress from laboratory to patients","volume":"26","author":"Sinden","year":"2017","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201902011","article-title":"Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membrane of engineered neural stem cells","volume":"15","author":"Ma","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib168","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acsnano.9b08587","article-title":"Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib169","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/acsnano.8b00477","article-title":"Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment","volume":"12","author":"Lv","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib170","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nnano.2017.170","article-title":"Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime","volume":"12","author":"Du","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib171","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib172","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75253-9","article-title":"Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood-brain barrier opening","volume":"10","author":"Ohta","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib173","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2019.07.026","article-title":"Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions","volume":"309","author":"Da Silva-Candal","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib174","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.2147\/IJN.S107292","article-title":"Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats","volume":"11","author":"Campos-Martorell","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2024.09.016_bib175","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1021\/nn5029955","article-title":"Acceleration of tissue plasminogen activator-mediated thrombolysis by magnetically powered nanomotors","volume":"8","author":"Cheng","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.09.016_bib176","doi-asserted-by":"crossref","first-page":"32988","DOI":"10.1021\/acsami.8b09423","article-title":"Tissue plasminogen activator-porous magnetic microrods for targeted thrombolytic therapy after ischemic stroke","volume":"10","author":"Hu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24004110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24004110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T04:31:25Z","timestamp":1733718685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X24004110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":176,"alternative-id":["S2452199X24004110"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.09.016","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology approaches to drug delivery for the treatment of ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}